These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8826824)

  • 41. Rosacea: Relative risk versus absolute risk of malignant comorbidities.
    Tjahjono LA; Cline A; Huang WW; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2019 Aug; 81(2):623-624. PubMed ID: 30654083
    [No Abstract]   [Full Text] [Related]  

  • 42. Wheezing, sneezing, and cancer risk - still an open door.
    Volkers N
    J Natl Cancer Inst; 1999 Nov; 91(22):1916-8. PubMed ID: 10564673
    [No Abstract]   [Full Text] [Related]  

  • 43. Impact of lymphopenia on prognosis of patients with primary central nervous system lymphoma.
    Schalk E; Zeremski V; Fischer T
    Eur J Cancer; 2017 Apr; 75():280-283. PubMed ID: 28249231
    [No Abstract]   [Full Text] [Related]  

  • 44. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield.
    Raina SK
    Neurol India; 2014; 62(3):343-4. PubMed ID: 25033875
    [No Abstract]   [Full Text] [Related]  

  • 45. [Primary central nervous system lymphoma].
    Makino K
    Nihon Rinsho; 2016 Sep; 74 Suppl 7():432-434. PubMed ID: 30634790
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter to the Editor Regarding "Natalizumab-Associated Primary Central Nervous System Lymphoma".
    Sartori D; Grundmark B
    World Neurosurg; 2018 Jul; 115():473-474. PubMed ID: 29958368
    [No Abstract]   [Full Text] [Related]  

  • 47. The challenge of adequate imaging surveillance in primary central nervous system lymphoma.
    Schlegel U; Korfel A
    Neuro Oncol; 2017 Mar; 19(3):307-308. PubMed ID: 28025387
    [No Abstract]   [Full Text] [Related]  

  • 48. Intraoperative Immunophenotypic Analysis for Diagnosis and Classification of Primary Central Nervous System Lymphomas.
    Vartholomatos G; Alexiou GA; Voulgaris S; Kyritsis AP
    World Neurosurg; 2018 Sep; 117():464-465. PubMed ID: 30149427
    [No Abstract]   [Full Text] [Related]  

  • 49. Insights in primary central nervous system lymphoma: a role for glymphatics?
    Kumaria A
    Brain Tumor Pathol; 2021 Oct; 38(4):290-291. PubMed ID: 34532755
    [No Abstract]   [Full Text] [Related]  

  • 50. Primary CNS lymphoma: in search of the evidence.
    Montserrat E
    Lancet Haematol; 2015 Jun; 2(6):e227-8. PubMed ID: 26688231
    [No Abstract]   [Full Text] [Related]  

  • 51. Low frequency of blood group A in primary central nervous system lymphoma.
    Gharouni M; Abouzari M; Rashidi A; Sodagari N; Behzadi M
    J Neurooncol; 2008 May; 87(3):363-4. PubMed ID: 18209953
    [No Abstract]   [Full Text] [Related]  

  • 52. Increasing incidence of primary central nervous system tumors in the elderly: real increase or improved detection?
    Helseth A
    J Natl Cancer Inst; 1993 Nov; 85(22):1871-2. PubMed ID: 8230273
    [No Abstract]   [Full Text] [Related]  

  • 53. Authors reply.
    Manoj N; Arivazhagan A; Mahadevan A; Bhat DI; Arvinda HR; Devi BI; Sampath S; Chandramouli BA
    Neurol India; 2014; 62(3):343. PubMed ID: 25181762
    [No Abstract]   [Full Text] [Related]  

  • 54. More Is Better, Especially When Radiation Is the Best Option….
    Parikh RR
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):402-403. PubMed ID: 32531383
    [No Abstract]   [Full Text] [Related]  

  • 55. Striking a Delicate Balance: Disease Control Without Neurotoxicity.
    Milgrom SA
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):401. PubMed ID: 32531381
    [No Abstract]   [Full Text] [Related]  

  • 56. [Central nervous system tumor: glioma].
    Takahashi H
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):676-7. PubMed ID: 26242003
    [No Abstract]   [Full Text] [Related]  

  • 57. Scottish Cancer Incidence Atlas 1985.
    Kemp I
    Recent Results Cancer Res; 1989; 114():137-42. PubMed ID: 2813929
    [No Abstract]   [Full Text] [Related]  

  • 58. Rare central nervous system tumors: the path to progress.
    Penas-Prado M
    Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S1-S3. PubMed ID: 34725695
    [No Abstract]   [Full Text] [Related]  

  • 59. Primary central nervous system lymphoma--a hospital based study of incidence and clinicopathological features from India (1980-2003).
    Sarkar C; Sharma MC; Deb P; Singh R; Santosh V; Shankar SK
    J Neurooncol; 2005 Jan; 71(2):199-204. PubMed ID: 15690139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary central nervous system lymphoma.
    Gavrilovic IT; Abrey LE
    Curr Oncol Rep; 2004 Sep; 6(5):388-95. PubMed ID: 15291982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.